Monday, January 22, 2018 10:15 PM ET
BeiGene (BGNE) sees Significant Insider buy Reversing Trend of Selling over Last Quarter
Notable insider buying activity was revealed in BeiGene shares in a form 4 document filed with the SEC today, showing — Baker Bros Advisors Lp, 10% Owner and Director — acquired 1,980,198 shares in the company having a net market value of approximately $199,999,998. There have been 3 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the selling of 407,301 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net purchases of 1,572,897 shares and have averaged 596,875 shares per transaction over this time period.
BeiGene insider trading represents a higher number of buy/sell trades than for the 280 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 336 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for BeiGene insiders was also higher. Within the peer group there were 44,054,825 shares purchased and 42,104,485 shares sold with company insiders acquiring 8,988 shares on average.
The data used in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.